Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Researcher

Shogen Boku

Kansai Medical University

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

SEP 10, 2026 · JOURNAL ARTICLE

Sterile neutrophilic pseudomembranous conjunctivitis associated with tisotumab vedotin: clinical and cytological evidence from two cases

BMC Ophthalmology

Two uncontrolled case reports describing a newly recognized adverse effect of tisotumab vedotin, with cytological mechanistic insight but no comparative data or systematic incidence assessment.

PreliminaryShogen Boku Megumi Kitamura Hisanori Imai

Reported

Number of cases2

Dose number at onset2 to 3 doses

Time to remissionwithin two weeks

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support